Lynda Spelman
11PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 05, 2025
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.April W Armstrong, Richard B Warren, Howard Sofen
|Feb 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette
|Oct 10, 2024
Quality-of-life evaluation in hidradenitis suppurativa in Australia: Validation and outcomes of the HiSQOL questionnaire.Kyle Wu, Conor Larney, Gill Marshman
|Jul 30, 2024
Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in Australia.Saxon D Smith, Simon Fifer, Meredith Edwards
|Oct 18, 2023
Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis.Junying Wang, Jeffery White, Kenneth J Sansone
|Sep 20, 2022
Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting.Peter Foley, Yves A Kerdraon, John P Hogden
Pageof 2
Frequent Collaborators
3 joint publications
Emma Guttman-Yassky
2 joint publications
Robert Bissonnette
1 joint publications
K M Darch
1 joint publications
K Papp
1 joint publications
M Gooderham
1 joint publications
K Yamanaka
1 joint publications
M Augustin
1 joint publications
J I Silverberg
1 joint publications
A Wollenberg
1 joint publications
A Blauvelt
